<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2013-1-19-22</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ИНИЦИАТИВА «STENT FOR LIFE» И ДИНАМИКА ВНЕДРЕНИЯ ПЕРВИЧНОГО ЧКВ В ЕВРОПЕ, 2008–2012 гг.</article-title><trans-title-group xml:lang="en"><trans-title>THE «STENT FOR LIFE» INITIATIVE AND THE DYNAMICS OF IMPLEMENTATION OF PRIMARY PCI IN EUROPE, 2008–2012</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Kala</surname><given-names>Petr</given-names></name><name name-style="western" xml:lang="en"><surname>Kala</surname><given-names>Petr</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медицинский факультет, MD, PhD, FESC, FSCAI</p></bio><bio xml:lang="en"><p>MD, PhD, FESC, FSCAI</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Университет им. Масарыка, Брно<country>Чехия</country></aff><aff xml:lang="en">Masaryk University and Fakultni nemocnice Brno, Brno<country>Czech Republic</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>26</day><month>06</month><year>2015</year></pub-date><volume>0</volume><issue>1</issue><fpage>19</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kala P., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Kala P.</copyright-holder><copyright-holder xml:lang="en">Kala P.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/3">https://www.nii-kpssz.com/jour/article/view/3</self-uri><abstract><p>Первичное чрескожное коронарное вмешательство (ЧКВ) – это предпочтительный и наиболее эффективный метод реперфузионной терапии в лечении пациентов с инфарктом миокарда с подъемом сегмента ST (ИМпST). Совершенствование системы выполнения первичного ЧКВ пациентам с ИМпST способствует значимому снижению уровня смертности. Стратегия лечения пациентов с ИМпST имеет множество различий как в Европе, так и за её пределами. Европейская инициатива «Stent for Life» может стать оптимальной моделью высокоэффективного междисциплинарного сотрудничества в здравоохранении не только на национальном, но даже на мировом уровне.</p></abstract><trans-abstract xml:lang="en"><p>Primary PCI is the preferred and most effective reperfusion therapy of patients with acute myocardial infarction with ST elevations (STEMI). By developing the healthcare system for primary PCI (STEMI patients) the highly signifi cant decrease of mortality can be observed. There is a large variation among the STEMI patients´ treatment in Europe and beyond. The European «Stent for Life» Initiative can serve as the best nation- or even worldwide model of highly effective interdisciplinary healthcare collaboration.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">A comparison of coronary angioplasty with fi brinolytic therapy in acute myocardial infarction / H. R. Andersen [et al.] // N. Engl. J. Med. 2003. Vol. 349. P. 733–742.</mixed-citation><mixed-citation xml:lang="en">A comparison of coronary angioplasty with fi brinolytic therapy in acute myocardial infarction / H. R. Andersen [et al.] // N. Engl. J. Med. 2003. Vol. 349. P. 733–742.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction / F. Zijlstra [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 680–684.</mixed-citation><mixed-citation xml:lang="en">A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction / F. Zijlstra [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 680–684.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction / C. L. Grines [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 673–679.</mixed-citation><mixed-citation xml:lang="en">A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction / C. L. Grines [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 673–679.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">ACC / AHA guidelines for the management of aptients with ST-elevation myocardial infarction – executive summary. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines / E. M. Antman [et al.] // J. Am. Coll. Cardiol. 2004. Vol. 44. P. 671–719.</mixed-citation><mixed-citation xml:lang="en">ACC / AHA guidelines for the management of aptients with ST-elevation myocardial infarction – executive summary. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines / E. M. Antman [et al.] // J. Am. Coll. Cardiol. 2004. Vol. 44. P. 671–719.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">How to set up an effective national primary angioplasty network: lessons learned from fi ve European countries / J. Knot [et al.] // EuroIntervention. 2009. Vol. 5 (299). P. 301–309.</mixed-citation><mixed-citation xml:lang="en">How to set up an effective national primary angioplasty network: lessons learned from fi ve European countries / J. Knot [et al.] // EuroIntervention. 2009. Vol. 5 (299). P. 301–309.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Long distance transport for primary angioplasty vs. Immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial – PRAGUE-2 / P.Widimsky [et al.] // Eur. Heart J. 2003. Vol. 24. P. 94–104.</mixed-citation><mixed-citation xml:lang="en">Long distance transport for primary angioplasty vs. Immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial – PRAGUE-2 / P.Widimsky [et al.] // Eur. Heart J. 2003. Vol. 24. P. 94–104.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the Euroopean Society of Cardiology / V. F. De Werf [et al.] // Eur. Heart. J. 2003. Vol. 24. P. 28–66.</mixed-citation><mixed-citation xml:lang="en">Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the Euroopean Society of Cardiology / V. F. De Werf [et al.] // Eur. Heart. J. 2003. Vol. 24. P. 28–66.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Reperfusion therapy for ST elevation acute myocardial infarction in Europe: descriptions of the current situation in 30 countries / P. Widimsky [et al.] // Eur Heart J. 2010. P. Vol. 31. P. 943–957.</mixed-citation><mixed-citation xml:lang="en">Reperfusion therapy for ST elevation acute myocardial infarction in Europe: descriptions of the current situation in 30 countries / P. Widimsky [et al.] // Eur Heart J. 2010. P. Vol. 31. P. 943–957.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
